Development of a multiroute physiologically based pharmacokinetic model for orbifloxacin in rabbits |
| |
| Authors: | F. Yang F. Yang W. Shi H. Si T. Kong G. Wang J. Zhang |
| |
| Affiliation: | 1. College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China;2. College of Animal Science and Technology, Guangxi University, Nanning, China |
| |
| Abstract: | To predict the orbifloxacin concentrations in rabbits after multiple routes of administration, a flow‐limited multiroute physiologically based pharmacokinetic (PBPK) model was developed. Three routes of administration (IV, IM, and PO) were incorporated into this model. Physiological parameters including tissue weights and blood flows through different tissues were obtained from the literature. The tissue/plasma partition coefficients (PXs) for noneliminating tissues were calculated according to the area method, while the PXs for kidney and the rest of the body compartment, together with other parameters for absorption and elimination, were optimized based on the published concentrations. The comparisons between predicted and observed orbifloxacin concentrations proved its validity, and the present model predicted available concentration data well, including those in liver, kidney, muscle, lung, heart, and plasma after oral, intravenous, or intramuscular administration. A local sensitivity analysis was also performed, which showed that the parameters for oral absorption were most influential on the orbifloxacin concentrations. This model was used to predict plasma and tissue concentrations after multiple oral or intramuscular administration. This study demonstrated the feasibility of predicting drug residues in minor species after multiple routes of administration in the extra‐label manner using the PBPK modeling. |
| |
| Keywords: | extra‐label use orbifloxacin physiologically based pharmacokinetic model rabbits residues |
|
|
